MEOX2 promotes glioma growth and temozolomide chemoresistance

Tengfei Li; Kaijun Sun; Wanchun Yang; Meiling Zhang; Wentao Feng; Siliang Chen; Mingrong Zuo; Qiuyun Yuan; Yanhui Liu; Mina Chen

doi:10.1016/j.jpha.2023.12.002

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2023 > Accepted Manu

Tengfei Li, Kaijun Sun, Wanchun Yang, Meiling Zhang, Wentao Feng, Siliang Chen, Mingrong Zuo, Qiuyun Yuan, Yanhui Liu, Mina Chen. MEOX2 promotes glioma growth and temozolomide chemoresistance[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2023.12.002

Citation:

Tengfei Li, Kaijun Sun, Wanchun Yang, Meiling Zhang, Wentao Feng, Siliang Chen, Mingrong Zuo, Qiuyun Yuan, Yanhui Liu, Mina Chen. MEOX2 promotes glioma growth and temozolomide chemoresistance[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2023.12.002

Citation:

Tengfei Li, Kaijun Sun, Wanchun Yang, Meiling Zhang, Wentao Feng, Siliang Chen, Mingrong Zuo, Qiuyun Yuan, Yanhui Liu, Mina Chen. MEOX2 promotes glioma growth and temozolomide chemoresistance[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2023.12.002

PDF( 4785 KB)

MEOX2 promotes glioma growth and temozolomide chemoresistance

doi: 10.1016/j.jpha.2023.12.002

a. Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China;
b. Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China;
c. Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China

Funds:

This work was supported by the grants from the Science and Technology Project, Technology Innovation Research and Development Project of Chengdu (Grant No.: 2022-YF05-01456-SN), Post-Doctor Research Project, West China Hospital, Sichuan University, China (Grant No.: 2021HXBH010), and the Natural Science Foundation of Sichuan Province of China (Grant No.: 2022NSFSC1428).

Received Date: Aug. 22, 2023
Accepted Date: Dec. 04, 2023
Rev Recd Date: Nov. 21, 2023
Available Online: Dec. 11, 2023

Abstract

FullText(HTML)

References(5)

References

C. Rouse, H. Gittleman, Q.T. Ostrom, et al., Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010, Neuro. Oncol. 18 (2016) 70−77.

D.N. Louis, A. Perry, P. Wesseling, et al., The 2021 WHO Classification of Tumors of the Central Nervous System: a summary, Neuro. Oncol. 23 (2021) 1231−1251.

T. Li, W. Yang, M. Li, et al., Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide, Cancer Cell Int. 20 (2020), 65.

J. Wang, Y. Chen, Q. Wang, et al., MEOX2-mediated regulation of Cathepsin S promotes cell proliferation and motility in glioma, Cell Death Dis. 13 (2022), 360.

A. Schonrock, E. Heinzelmann, B. Steffl, et al., MEOX2 homeobox gene promotes growth of malignant gliomas, Neuro. Oncol. 24 (2022) 1911−1924.

Relative Articles

Supplements(0)

Cited By

Proportional views